Archean Chemical Industries Ltd Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Q4 FY26 earnings call analysis: revenue, margin, capex, fundraise and order book outlook from management commentary.

Published 24 May 2026 | Chemicals & Petrochemicals | Market Cap: ₹6.5K Cr

Bromine production is expected to grow by 15%-20% annually, aiming to increase from ~20,000 tons to 25,000 tons next year, and eventually to 40,000 tons over time. Company aims for volume growth in core bromine and salt businesses, targeting 15%-20% annual bromine production growth, moving from ~20,000 tons to 25,000 tons next year and planning eventual capacity up to 40,000 tons.

From Archean Chemical Industries Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Price

₹498

Market Cap

₹6.5K Cr

P/E Ratio

66.8

How does Archean Chemical Industries Ltd rank in Chemicals & Petrochemicals?

Compare Archean Chemical Industries Ltd against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Archean Chemical Industries Ltd — Quarterly revenue & net profit

Revenue Net Profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹301 Cr, net profit ₹12 Cr.

Full financials →

📊 Revenue & Sales Performance

→Bromine production is expected to grow by 15%-20% annually, aiming to increase from ~20,000 tons to 25,000 tons next year, and eventually to 40,000 tons over time.
→Industrial Salt business is anticipated to grow at 10%-12% annually, supported by brine field expansion enhancing both salt and liquor production for bromine.
→Bromine derivatives business is scaling up, with volume sales and revenue sharply increasing; focus on product development and capacity utilization improvements.
→SOP business is undergoing reengineering and is expected to scale up production from the second half of the year.
→Overall, the company is targeting volume growth across all core businesses through market penetration, product development, and long-term customer partnerships.
→Revenue growth is moderate due to pricing pressures but expected to improve with stabilization of costs and logistics, aiming at historical margin levels.

📈 Profitability & Margins

→Company aims for volume growth in core bromine and salt businesses, targeting 15%-20% annual bromine production growth, moving from ~20,000 tons to 25,000 tons next year and planning eventual capacity up to 40,000 tons.
→Industrial Salt expected to grow at 10%-12% annually, supported by brine field expansion.
→Bromine derivatives and oilfield chemicals businesses being scaled up, with new product launches and process optimizations underway to improve margins and utilization (currently ~45% capacity utilization).
→Expecting operational improvements and cost optimizations (logistics, process efficiencies) to aid margin recovery to historical levels as external cost pressures ease.
→SOP business undergoing reengineering; higher production expected in second half of FY27.
→No specific forward-looking EBITDA or profit guidance, but management focuses on disciplined capital allocation toward high-return growth projects.
→Growth in semiconductor-related advanced materials anticipated, with a 24-30 month ramp-up timeline starting July 2026.

See what Archean Chemical Industries Ltd said on profitability & margins — free account, 30 seconds.

🏗️ Capital Expenditure Plans

→The company is investing in strategic long-term opportunities in advanced materials, specifically in batteries and semiconductors.
→A pilot line for wafer manufacturing is under development at IIT Bhubaneshwar through SiCSem, with ongoing capital expenditure under intellectual property development and technology transfer agreements.
→A new area for expanding the brine pond has been established to enhance bromine production capacity, aiming for increased peak production around FY27 or FY28.
→Investments are focused on scaling up derivatives, oilfield, and SOP businesses alongside consolidating core salt and bromine businesses.
→Capital discipline is emphasized, with a focus on investing in projects with good returns and scaling existing businesses efficiently.
→No specific capex amount or timeline disclosed, but planned semiconductor plant production is expected 24-30 months from July of the current year.

💰 Fundraising & Capital Structure

→The transcript does not mention any current or planned fundraising through debt or equity.
→The management emphasizes capital discipline, focusing on investing in high-return growth projects.
→There is no specific guidance given on raising new debt or equity.
→The company aims for effective capital allocation but has not indicated any immediate plans for external fundraising.
→CEO Rampraveen Swaminathan explicitly states they do not provide forward-looking statements about debt levels or fundraising.
→The focus remains on scaling existing businesses and driving returns from current investments.

See what Archean Chemical Industries Ltd said on fundraising & capital structure — free account, 30 seconds.

📋 Order Book & Pipeline

The provided document does not explicitly mention the current or expected order book or pending orders for Archean Chemical Industries Limited. However, some relevant points related to demand and orders can be summarized: - Industrial Salt volumes faced some deferrals and shipment challenges due to logistics and geopolitical issues impacting orders. - There are references to long-term customers in specific geographies maintaining stable pricing, suggesting ongoing order relationships. - Growth in demand is tied to geographic and application-specific factors, with faster-growing geographies providing benefits. - No specific figures or details on order book size or pending orders were disclosed in the available excerpts.

Key Metrics

How does Archean Chemical Industries Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

1Archean Chemical Industries Ltd

See full Chemicals & Petrochemicals sector rankings

What ACI's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

NOCIL (Q4 FY26)
The Rs.130 crores capex includes some intermediates and is largely for captive consumption, with part allocated to finished goods. Key concall takeaways from…
Indo Borax & Chemicals Ltd (Q4 FY26)
175 crores revenue in the previous financial year and Rs. Key concall takeaways from Indo Borax & Chemicals Ltd's Q4 FY26 earnings call — and how it ranks…
ROSSARI (Q4 FY26)
50-70 crore planned for FY27 focused on pharma and aroma chemical facilities to support value-added product segments. Key concall takeaways from Rossari…
PIDILITIND (Q4 FY26)
Underlying volume growth (UVG) averaged over 9% per quarter last year, with a ~200 bps increase in FY '25; the company plans to continue lifting UVG…

Compare:vs Solar Industries India Ltd vs PIDILITIND vs SRF

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Archean Chemical Industries Ltd Q4 FY26 results?

What is Archean Chemical Industries Ltd share price analysis?

Archean Chemical Industries Ltd currently shows a neutral. The stock trades at a P/E of 66.8 with a market cap of ₹6,467 Cr. Investors should review the full earnings analysis for detailed insights.

Is Archean Chemical Industries Ltd planning capital expenditure?

The company is investing in strategic long-term opportunities in advanced materials, specifically in batteries and semiconductors.

Keep Archean Chemical Industries Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.